
2000 From: Ketchum
New cost-effectiveness data may transform the prescribing for schizophrenia treatments around the worldSchizophrenia -- The Real Cost Exploring the Cost Equation Renacimiento II Room, Miguel Angel Hotel, Madrid, Spain 27 April 2000, 11:30am local time P R E S S B R I E F I N G 11.30 Welcome & Introduction Professor Siegfried Kasper (Chairman) 11.35 The Human Cost of Schizophrenia Gary Hogman, National Schizophrenia Fellowship (UK) 11.45 Why Cost Matters Professor Martin Knapp, London School of Economics, (UK) 11.55 Studying Real-Life Outcomes Dr Koen Torfs 12.05 RODOS: Results Professor Siegfried Kasper, University Hospital for Psychiatry, Vienna 12.25 Relapse Prevention -- The Long-Term Goal Dr Richard Williams, Canada 12.45 Questions to the Panel 13.05 Chairman's Conclusions 13.10 Close: Buffet lunch will be served
|